Lartruvo
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lartruvo, covering 2019-01-23 to 2019-09-02. Get the full timeline:
Most recent: EMA Revoked: Lartruvo (olaratumab) — Eli Lilly Nederland B.V.
3 regulatory and trial events tracked for Lartruvo, covering 2019-01-23 to 2019-09-02. Get the full timeline:
Most recent: EMA Revoked: Lartruvo (olaratumab) — Eli Lilly Nederland B.V.